PI3K/mTOR Inhibitor Demonstrates Efficacy in Some Uterine Sarcomas
Oncology Nurse Advisor ,
March 08, 2017 Leiomyosarcomas account for 30% of all uterine sarcomas and are difficult to treat.
March 08, 2017 Leiomyosarcomas account for 30% of all uterine sarcomas and are difficult to treat.
March 08, 2017 Leiomyosarcomas account for 30% of all uterine sarcomas and are difficult to treat.
PHILADELPHIA — The protein P-S6S240 may serve as an indicator of poor prognosis for patients with a hard-to-treat type of…
The protein P-S6S240 may serve as an indicator of poor prognosis for patients with a hard-to-treat type of uterine sarcoma…